1. 19LBA Docetaxel (Doc) +/− zoledronic acid (ZA) for hormone-naive prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476). Issue 3 (September 2015) Authors: James, N.D.; Sydes, M.R.; Mason, M.D.; Clarke, N.W.; Dearnaley, D.P.; Spears, M.R.; Millman, R.; Parker, C.C.; Ritchie, A.W.S.; Russell, J.M.; Staffurth, J.; Jones, R.J.; Cathomas, R.; Robinson, A.; Chowdhury, S.; Tsang, D.; Brock, S.; Parikh, O.; Graham, J.D.; Parmar, M.K.B. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 20LBA What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses. (September 2015) Authors: Vale, C.; Rydzewska, L.H.; Tierney, J.F.; Albiges, L.; Clarke, N.W.; Fisher, D.J.; Fizazi, K.; James, N.D.; Mason, M.D.; Parmar, M.K.; Sweeney, C.J.; Sydes, M.R.; Tombal, B.; Burdett, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2525 ASPIRE-PCa: Initial findings from a prospective, global observational study of men with late-stage prostate cancer. (September 2015) Authors: De Santis, M.; Costello, A.; Chang, Y.H.; Clarke, N.W.; Pickles, T.; Bellm, L.A.; Haas, G.P.; Pompeo, A.C.; Bazarbashi, S.; Cooperberg, M.R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study. Issue 8 (August 2020) Authors: Sujenthiran, A.; Parry, M.; Nossiter, J.; Berry, B.; Cathcart, P.J.; Clarke, N.W.; Payne, H.; van der Meulen, J.; Aggarwal, A. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Metastatic Burden in Hormone-Naive Prostate Cancer: A Tale of Two Subgroups. Issue 3 (March 2020) Authors: Haran, Á.M.; Ali, A.; Clarke, N.W. Journal: Clinical oncology Issue: Volume 32:Issue 3(2020) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. RADICALS-HD: Reflections before the Results are Known. Issue 9 (September 2022) Authors: Parker, C.C.; Clarke, N.W.; Catton, C.; Kynaston, H.; Cook, A.; Cross, W.; Davidson, C.; Goldstein, C.; Logue, J.; Maniatis, C.; Petersen, P.M.; Neville, P.; Payne, H.; Persad, R.; Pugh, C.; Stirling, A.; Saad, F.; Parulekar, W.R.; Parmar, M.K.B.; Sydes, M.R. Journal: Clinical oncology Issue: Volume 34:Issue 9(2022) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al. Issue 10 (October 2016) Authors: James, N.D.; Sydes, M.R.; Clarke, N.W.; Ritchie, A.W.S.; Parmar, M.K.B. Journal: Clinical oncology Issue: Volume 28:Issue 10(2016) Page Start: 666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The prognostic potential of the long non-coding RNA MALAT1 in prostate cancer. (July 2016) Authors: Hiew, K.; Bokobza, S.M.; Hart, C.A.; Elliott, T.; Smith, N.R.; Brown, M.; Clarke, N.W. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗